BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 33710655)

  • 41. Usefulness of texture and color enhancement imaging in assessing mucosal healing in patients with ulcerative colitis.
    Hayashi Y; Takabayashi K; Kato M; Tojo A; Aoki Y; Hagihara Y; Yoshida K; Yoshimatsu Y; Kiyohara H; Sugimoto S; Nanki K; Mikami Y; Sujino T; Mutaguchi M; Kawaguchi T; Hosoe N; Yahagi N; Ogata H; Kanai T
    Gastrointest Endosc; 2023 Apr; 97(4):759-766.e1. PubMed ID: 36460084
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histological Risk Factors to Predict Clinical Relapse in Ulcerative Colitis With Endoscopically Normal Mucosa.
    Ozaki R; Kobayashi T; Okabayashi S; Nakano M; Morinaga S; Hara A; Ohbu M; Matsuoka K; Toyonaga T; Saito E; Hisamatsu T; Hibi T
    J Crohns Colitis; 2018 Nov; 12(11):1288-1294. PubMed ID: 29939231
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study.
    Barreiro-de Acosta M; Vallejo N; de la Iglesia D; Uribarri L; Bastón I; Ferreiro-Iglesias R; Lorenzo A; Domínguez-Muñoz JE
    J Crohns Colitis; 2016 Jan; 10(1):13-9. PubMed ID: 26351390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
    World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission.
    Kim JH; Cheon JH; Park Y; Lee HJ; Park SJ; Kim TI; Kim WH
    Scand J Gastroenterol; 2016 Sep; 51(9):1069-74. PubMed ID: 26895215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patient-reported Outcomes and Disability Are Associated with Histological Disease Activity in Patients with Ulcerative Colitis: Results from the APOLLO Study.
    Verstockt B; Pouillon L; Ballaux F; Jorissen C; Hoefkens E; Lembrechts N; Bossuyt P
    J Crohns Colitis; 2023 Jul; 17(7):1046-1054. PubMed ID: 36708189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A prospective study on second-generation colon capsule endoscopy to detect mucosal lesions and disease activity in ulcerative colitis (with video).
    Shi HY; Chan FKL; Higashimori A; Kyaw M; Ching JYL; Chan HCH; Chan JCH; Chan AWH; Lam KLY; Tang RSY; Wu JCY; Sung JJY; Ng SC
    Gastrointest Endosc; 2017 Dec; 86(6):1139-1146.e6. PubMed ID: 28713062
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical value of the Toronto inflammatory bowel disease global endoscopic reporting score in ulcerative colitis.
    Liu XY; Tian ZB; Zhang LJ; Liu AL; Zhang XF; Wu J; Ding XL
    World J Gastroenterol; 2023 Dec; 29(48):6208-6221. PubMed ID: 38186862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel endoscopic imaging system for quantitative evaluation of colonic mucosal inflammation in patients with quiescent ulcerative colitis.
    Honzawa Y; Matsuura M; Higuchi H; Sakurai T; Seno H; Nakase H
    Endosc Int Open; 2020 Jan; 8(1):E41-E49. PubMed ID: 31921983
    [No Abstract]   [Full Text] [Related]  

  • 50. Mucosal concentrations of N-acetyl-5-aminosalicylic acid related to endoscopic activity in ulcerative colitis patients with mesalamine.
    Fukuda T; Naganuma M; Takabayashi K; Hagihara Y; Tanemoto S; Nomura E; Yoshimatsu Y; Sugimoto S; Nanki K; Mizuno S; Mikami Y; Fukuhara K; Sujino T; Mutaguchi M; Inoue N; Ogata H; Iwao Y; Abe T; Kanai T
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1878-1885. PubMed ID: 32250471
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitis.
    Nardone OM; Bazarova A; Bhandari P; Cannatelli R; Daperno M; Ferraz J; Goetz M; Gui X; Hayee B; De Hertogh G; Lazarev M; Li J; Parra-Blanco A; Pastorelli L; Panaccione R; Occhipinti V; Rath T; Smith SCL; Shivaji UN; Tontini GE; Vieth M; Villanacci V; Zardo D; Bisschops R; Kiesslich R; Ghosh S; Iacucci M
    United European Gastroenterol J; 2022 Mar; 10(2):147-159. PubMed ID: 35194978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis.
    Viscido A; Valvano M; Stefanelli G; Capannolo A; Castellini C; Onori E; Ciccone A; Vernia F; Latella G
    BMC Gastroenterol; 2022 Mar; 22(1):92. PubMed ID: 35240984
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation of Intestinal Mucosal Healing and Tight Junction Protein Expression in Ulcerative Colitis Patients.
    Tan Y; Guan Y; Sun Y; Zheng C
    Am J Med Sci; 2019 Mar; 357(3):195-204. PubMed ID: 30638599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complete mucosal healing defined by endoscopic Mayo subscore still demonstrates abnormalities by novel high definition colonoscopy and refined histological gradings.
    Iacucci M; Fort Gasia M; Hassan C; Panaccione R; Kaplan GG; Ghosh S; Gui X
    Endoscopy; 2015 Aug; 47(8):726-34. PubMed ID: 25826276
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Further research on the clinical relevance of the ulcerative colitis colonoscopic index of severity for predicting 5-year relapse.
    Ishida N; Onoue S; Miyazu T; Tamura S; Tani S; Yamade M; Iwaizumi M; Hamaya Y; Osawa S; Furuta T; Sugimoto K
    Int J Colorectal Dis; 2021 Dec; 36(12):2661-2670. PubMed ID: 34409500
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validation of red dichromatic imaging score (RDI score) to evaluate the severity of ulcerative colitis.
    Hashimoto Y; Kuribayashi S; Sato K; Itoi Y; Nakata K; Kasuga K; Tanaka H; Hosaka H; Ikota H; Iacucci M; Uraoka T
    Surg Endosc; 2023 May; 37(5):3627-3633. PubMed ID: 36627537
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study.
    Prieux-Klotz C; Nahon S; Amiot A; Sinayoko L; Galéano-Cassaz C; Chaussade S; Coriat R; Lahmek P; Abitbol V
    Dig Dis Sci; 2017 Feb; 62(2):473-480. PubMed ID: 27853898
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Improved Mayo Endoscopic Score has a higher value for evaluating clinical severity of ulcerative colitis].
    Song Z; Zhang M; Ren Y; Iang B
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jul; 42(7):997-1005. PubMed ID: 35869761
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical, endoscopic and histological correlation and measures of association in ulcerative colitis.
    Fluxá D; Simian D; Flores L; Ibáñez P; Lubascher J; Figueroa C; Kronberg U; Pizarro G; Castro M; Piottante A; Vial MT; Quera R
    J Dig Dis; 2017 Nov; 18(11):634-641. PubMed ID: 28949435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
    Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.